Isosorbide Dinitrate And Hydralazine Hydrochloride Tablet, Film Coated
Product Images NDC 72319-012

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Isosorbide Dinitrate And Hydralazine Hydrochloride (NDC 72319-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Not available*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Hcl (Hcl)

FDA Label Image

Isdn-label (Isdn Label)

This is a description of a medication. Each tablet contains 20 mg of isosorbide dinitrate and 37.5 mg of hydralazine HCI. The medication is manufactured by i3 Pharmaceuticals, LLC and comes in a bottle with 180 tablets. The usual dosage should be specified in the package insert. The medication should be stored at room temperature between 15°C-30°C (59°F - 86°F). For more information, visit the website www.i3pharmaceuticals.com.*

FDA Label Image

Isdn (Isdn)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.